Published Date: 12 Jun 2023
The standard clinical risk model was outperformed by artificial intelligence (AI) algorithms in a large study involving thousands of mammograms.
Read Full NewsAI is saving clinicians time, but the majority of healthcare professionals say training in the technology is inadequate, inconsistent or unavailable, a global survey...
The recent hantavirus outbreak underscores how urbanization, deforestation, and rodent reservoirs can converge to shape zoonotic risk.
Dr Maurie Markman discusses a PLCO trial analysis highlighting the stark association between consistent heavy drinking and increased colorectal cancer risk.
The short answer is yes. Dr F. Perry Wilson explains why he believes AI still has a role in radiology.
A medical oncologist seeks to use his computer science knowledge to make AI understandable to the medical community.
Dr Emil Lou breaks down practice-changing GI oncology data from ASCO 2026, including transformative survival updates in pancreatic and upper GI cancers.
As menopause has become more visible online, experts see both benefits and risks, from greater patient engagement to the spread of misinformation.
1.
FDA-approved FGFR inhibitors show promise against rare and aggressive pediatric brain tumor
2.
ASCO: GLP-1 receptor agonists may reduce risk for obesity-related cancer, all-cause death
3.
Men With Prostate Cancer Experience Less Hot Flashes When Using an Affordable Drug.
4.
GLP-1 drugs linked to dramatically lower death rates in colon cancer patients
5.
Underprescribed for Alcohol Use Disorder is pharmacotherapy.
1.
Chloride Test in HCC: Diagnostic Utility, Prognostic Role, and Emerging Insights
2.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
3.
Amivantamab Plus Chemotherapy Outperforms Standard Care in Post-Osimertinib NSCLC
4.
Predicting Incidental Prostate Cancer in BPH Surgery Patients
5.
The Genetics of Bernard Soulier Syndrome: What We Know so Far
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Navigating the Complexities of Ph Negative ALL - Part V
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
4.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V
5.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation